1. Home
  2. QTTB vs LAND Comparison

QTTB vs LAND Comparison

Compare QTTB & LAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.46

Market Cap

450.1M

Sector

Health Care

ML Signal

N/A

Logo Gladstone Land Corporation

LAND

Gladstone Land Corporation

N/A

Current Price

$9.52

Market Cap

414.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
QTTB
LAND
Founded
2015
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
450.1M
414.1M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
QTTB
LAND
Price
$8.46
$9.52
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
★ $42.25
$9.33
AVG Volume (30 Days)
★ 605.5K
601.8K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 5.92%
EPS Growth
★ 136.78
N/A
EPS
N/A
★ N/A
Revenue
$53,737,000.00
★ $88,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$150.00
$4.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$1.91
$7.92
52 Week High
$23.57
$13.00

Technical Indicators

Market Signals
Indicator
QTTB
LAND
Relative Strength Index (RSI) 24.42 53.51
Support Level $5.12 $9.10
Resistance Level $16.85 $9.73
Average True Range (ATR) 0.68 0.21
MACD -0.13 -0.05
Stochastic Oscillator 5.86 32.32

Price Performance

Historical Comparison
QTTB
LAND

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: